Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe rheumatoid arthritis. These highlights do not include all the information needed to use Enbrel safely and effectively. See full prescribing information for Enbrel. Enbrel® (etanercept). What is Enbrel (etanercept) and what is it used for? of Product Characteristics ( SPC) for Enbrel these can be found at the electronic Medicines Compendium.
|Published (Last):||13 June 2005|
|PDF File Size:||18.1 Mb|
|ePub File Size:||1.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
Marketing authorisation number s 9. At week8 subjects had progressed to a score of bilateral Grade 2 on spinal X-ray according to the modified New York Radiological Grade, indicative of axial spondyloarthropathy. Flexible and convenient treatment options, compatible with modern lifestyle, are important in helping patients maintain treatment and manage their disease. The central volume of distribution of etanercept is 7.
Etanercept has been reported to be excreted in human milk following subcutaneous administration. Distribution A biexponential curve is required to describe the concentration time curve of etanercept. Offer subject to change or discontinuation without notice. Enbrel 50mg solution for injection in pre-filled syringe.
The efficacy of Enbrel was assessed in a randomised, double-blind, placebo-controlled study in patients with psoriatic arthritis. Reporting suspected adverse reactions after authorisation of the medicinal product is important. In the absence of compatibility ejbrel, this medicinal product must not be mixed with other medicinal products.
Patients who did not complete 12 months in the study were considered to be non-responders. The safety and efficacy of Enbrel in xpc with chronic infections have not been evaluated. After 12 weeks of treatment, patients in the placebo group began treatment with blinded Enbrel 25 mg twice a week ; patients in the active treatment groups continued to week 24 on the dose to which they were originally randomised.
Injection site reactions and upper respiratory infections sinus infections. Study 2 evaluated patients with chronic plaque psoriasis using the same inclusion criteria as study 1 with the addition of a minimum psoriasis area and severity index PASI of 10 at screening. Mean duration was approximately 3 to 5 days. If re-treatment with Enbrel is indicated, the above guidance on treatment duration should be followed. The recommended dose is 25 mg Enbrel administered twice weekly, or 50 mg administered once weekly.
Dose proportionality has not been formally evaluated, but there is no apparent saturation of clearance across the dosing range.
Enbrel 10 mg powder and solvent nebrel solution for injection for pediatric use. In the double-blind periods of controlled clinical trials that allowed concomitant treatment with wpc and methotrexate, the ennbrel incidence proportion of adverse events of elevated liver enzymes was 4. An analysis of clinical trial data did not reveal any baseline disease characteristics that would assist clinicians in selecting the most appropriate dosing option intermittent or continuous. In lactating rats following subcutaneous administration, etanercept was excreted in the milk and detected in the serum of pups.
Several adverse events were reported more commonly in 69 juvenile idiopathic arthritis patients receiving 3 months of Enbrel compared to the adult rheumatoid arthritis patients.
Patients with a significant exposure to varicella virus should temporarily discontinue Enbrel therapy and be considered for prophylactic treatment with Varicella Zoster Immune Globulin.
Enbrel is not recommended during pregnancy. The presence of hepatic impairment should not require a change in dosage. Results Results and statistical analysis from stability testing across the etanercept DP presentations are described below.
Treatment with Enbrel should continue until remission is achieved, for up to 24 weeks. Serious haematological, neurological and autoimmune reactions have also been reported. Journal List Clin Pharmacol v.
At week 12, more patients randomised to Enbrel had positive efficacy responses e. Please see Prescribing Enbrdl and Medication Guide. Consequently, the choice of intermittent or continuous therapy should be based upon physician judgment and individual patient needs.